Health Care & Life Sciences » Pharmaceuticals | Dongsung Pharmaceutical Co. Ltd.

Dongsung Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
18,396
30,109
21,063
17,695
15,693
31,433
Total Accounts Receivable
47,243
43,800
43,161
41,543
40,265
35,883
Inventories
12,687
12,785
10,964
14,868
16,332
17,360
Other Current Assets
825
380
1,833
2,975
2,231
3,114
Total Current Assets
79,151
87,075
77,021
77,080
74,521
87,789
Net Property, Plant & Equipment
32,199
32,171
31,883
33,214
34,402
34,507
Total Investments and Advances
14,707
14,472
14,067
13,802
13,790
13,532
Long-Term Note Receivable
92
92
92
92
92
2,448
Intangible Assets
751
454
1,053
988
1,187
882
Other Assets
191
-
-
210
194
227
Total Assets
127,090
134,264
124,116
125,386
124,185
140,196
ST Debt & Current Portion LT Debt
37,104
37,597
37,464
20,096
19,183
Accounts Payable
9,054
12,800
10,338
11,100
11,454
Income Tax Payable
-
9,439
513
455
-
Other Current Liabilities
6,563
5,113
4,949
6,809
6,048
Total Current Liabilities
52,721
64,949
53,265
38,461
36,684
Long-Term Debt
1,684
2,461
2,022
19,971
12,041
Provision for Risks & Charges
5,531
5,887
5,073
6,271
6,308
Deferred Taxes
1,687
1,400
1,625
615
433
Other Liabilities
3,988
3,962
4,396
4,448
4,448
Total Liabilities
65,611
78,659
66,381
69,766
59,914
Common Equity (Total)
61,479
55,605
57,735
55,621
64,271
Total Shareholders' Equity
61,479
55,605
57,735
55,621
64,271
Total Equity
61,479
55,605
57,735
55,621
64,271
Liabilities & Shareholders' Equity
127,090
134,264
124,116
125,386
124,185

About Dongsung Pharmaceutical Co.

View Profile
Address
683 Dobong-ro
Seoul SL 01340
Korea, Republic Of
Employees -
Website http://www.dongsung-pharm.co.kr
Updated 07/08/2019
Dongsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals. It operates through following business divisions: Pharmaceutical and Cosmetic. Its products include general and special medicines such anti-rheumatic and anti-inflammatory analgesics, anti-inflammatory enzymes, cardiovascular system, gastrintestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dematologicals, antibiotics, antidiarreals, antifungals, oral hypoglycemic agents, hormones and tranquillizers.